Literature DB >> 33572700

Immunohistochemical Markers in Endometrial Cancer.

Valerio Mais1, Michele Peiretti2.   

Abstract

In 2018, 382,069 new cases of uterine cancer were registered worldwide and 89,929 deaths from this cancer were reported [...].

Entities:  

Year:  2021        PMID： 33572700      PMCID： PMC7865610          DOI： 10.3390/cancers13030505

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN： 2072-6694            Impact factor:   6.639


  16 in total

1.  Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumor Analysis)-4 cohort.

Authors:  J Y Verbakel; F Mascilini; L Wynants; D Fischerova; A C Testa; D Franchi; F Frühauf; D Cibula; P G Lindqvist; R Fruscio; L A Haak; G Opolskiene; J L Alcazar; V Mais; J W Carlson; P Sladkevicius; D Timmerman; L Valentin; T Van Den Bosch; E Epstein
Journal:  Ultrasound Obstet Gynecol       Date:  2019-12-13       Impact factor: 7.299

2.  Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.

Authors:  Sergio Pecorelli
Journal:  Int J Gynaecol Obstet       Date:  2009-05       Impact factor: 3.561

3.  Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.

Authors:  Aline Talhouk; Melissa K McConechy; Samuel Leung; Winnie Yang; Amy Lum; Janine Senz; Niki Boyd; Judith Pike; Michael Anglesio; Janice S Kwon; Anthony N Karnezis; David G Huntsman; C Blake Gilks; Jessica N McAlpine
Journal:  Cancer       Date:  2017-01-06       Impact factor: 6.860

4.  Feasibility of hand-assisted laparoscopic sentinel node biopsy in open endometrial cancer surgery.

Authors:  Michele Peiretti; Giorgio Candotti; Alessandro Buda; Ignacio Zapardiel; Daniela Fanni; Anna Proto; Maria Luisa Fais; Valerio Mais
Journal:  Minim Invasive Ther Allied Technol       Date:  2019-06-12       Impact factor: 2.442

5.  L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile.

Authors:  Felix Kf Kommoss; Anthony N Karnezis; Friedrich Kommoss; Aline Talhouk; Florin-Andrei Taran; Annette Staebler; C Blake Gilks; David G Huntsman; Bernhard Krämer; Sara Y Brucker; Jessica N McAlpine; Stefan Kommoss
Journal:  Br J Cancer       Date:  2018-07-27       Impact factor: 7.640

6.  ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Xavier Matias-Guiu; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio Gonzalez Martin; Sigurd Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina Sturdza; Alexandra Taylor; Anneke Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Carien L Creutzberg
Journal:  Int J Gynecol Cancer       Date:  2020-12-18       Impact factor: 3.437

7.  Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study.

Authors:  Casper Reijnen; Evangelia Gogou; Nicole C M Visser; Hilde Engerud; Jordache Ramjith; Louis J M van der Putten; Koen van de Vijver; Maria Santacana; Peter Bronsert; Johan Bulten; Marc Hirschfeld; Eva Colas; Antonio Gil-Moreno; Armando Reques; Gemma Mancebo; Camilla Krakstad; Jone Trovik; Ingfrid S Haldorsen; Jutta Huvila; Martin Koskas; Vit Weinberger; Marketa Bednarikova; Jitka Hausnerova; Anneke A M van der Wurff; Xavier Matias-Guiu; Frederic Amant; Leon F A G Massuger; Marc P L M Snijders; Heidi V N Küsters-Vandevelde; Peter J F Lucas; Johanna M A Pijnenborg
Journal:  PLoS Med       Date:  2020-05-15       Impact factor: 11.069

8.  Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.

Authors:  Alicia León-Castillo; Ester Gilvazquez; Remi Nout; Vincent Thbm Smit; Jessica N McAlpine; Melissa McConechy; Stefan Kommoss; Sara Y Brucker; Joseph W Carlson; Elisabeth Epstein; Tilman T Rau; Robert A Soslow; Raji Ganesan; Xavier Matias-Guiu; Esther Oliva; Beth T Harrison; David N Church; C Blake Gilks; Tjalling Bosse
Journal:  J Pathol       Date:  2020-01-12       Impact factor: 7.996

9.  Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.

Authors:  Alicia León-Castillo; Stephanie M de Boer; Melanie E Powell; Linda R Mileshkin; Helen J Mackay; Alexandra Leary; Hans W Nijman; Naveena Singh; Pamela M Pollock; Paul Bessette; Anthony Fyles; Christine Haie-Meder; Vincent T H B M Smit; Richard J Edmondson; Hein Putter; Henry C Kitchener; Emma J Crosbie; Marco de Bruyn; Remi A Nout; Nanda Horeweg; Carien L Creutzberg; Tjalling Bosse
Journal:  J Clin Oncol       Date:  2020-08-04       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.